Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $381.8200 (-2.01%) ($381.8200 - $381.8200) on Fri. Feb. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.83% (three month average) | RSI | 45 | Latest Price | $381.8200(-2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.4% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(48%) IVW(41%) IWF(41%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.915% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-5%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.915% (StdDev 1.83%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $368.36(3.65%) | 10 Day Moving Average | $354.85(7.6%) | 20 Day Moving Average | $363.21(5.12%) | To recent high | -2.3% | To recent low | 17% | Market Cap | $40.484b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |